Enhanced Intestinal Absorption of Cholesterol along with Increased Chylomicron Remnants for De novo Progression of Coronary Stenosis.
Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine.
Daisaku
D
Masuda
Shizuya
S
Yamashita
D000924:Anticholesteremic Agents / Q000009:adverse effects; D053283:Apolipoprotein B-48 / Q000378:metabolism; D015415:Biomarkers / Q000378:metabolism; D002784:Cholesterol / Q000378:metabolism*; D053298:Chylomicron Remnants / Q000378:metabolism*; D003324:Coronary Artery Disease / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D023921:Coronary Stenosis / Q000209:etiology / Q000378:metabolism / Q000473:pathology*; D006801:Humans; D007408:Intestinal Absorption / Q000187:drug effects*; D062645:Percutaneous Coronary Intervention / Q000009:adverse effects; D011379:Prognosis
D000924:Anticholesteremic Agents; D053283:Apolipoprotein B-48; D015415:Biomarkers; D053298:Chylomicron Remnants; D002784:Cholesterol